Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

4.99
Delayed Data
As of 4:00pm ET
 -0.17 / -3.29%
Today’s Change
4.21
Today|||52-Week Range
14.41
-12.76%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close5.16
Today’s open5.18
Day’s range4.95 - 5.32
Volume406,791
Average volume (3 months)1,284,983
Market cap$428.2M
Dividend yield--
Data as of 4:00pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-154.67%
Earnings growth (this year)+18.99%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+25.59%
P/E ratioNM
Price/Sales2.40
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
PLSEPulse Biosciences In...-1.98-7.33%
RMTIRockwell Medical Inc-0.29-3.95%
SRDXSurModics Inc-0.55-1.99%
ATRSAntares Pharma Inc-0.10-3.15%
Data as of 4:00pm ET, 07/27/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$192.9M
Annual profit (last year)-$154.7M
Net profit margin-80.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts